These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6855778)

  • 21. Regulation of complement functional efficiency by histidine-rich glycoprotein.
    Chang NS; Leu RW; Rummage JA; Anderson JK; Mole JE
    Blood; 1992 Jun; 79(11):2973-80. PubMed ID: 1375119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherited C8 beta subunit deficiency in a patient with recurrent meningococcal infections: in vivo functional kinetic analysis of C8.
    Rao CP; Minta JO; Laski B; Alper CA; Gelfand EW
    Clin Exp Immunol; 1985 Apr; 60(1):183-90. PubMed ID: 3924449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene responsible for deficient activity of the beta subunit of C8, the eighth component of complement, is located on mouse chromosome 4.
    Tanaka S; Suzuki T; Sakaizumi M; Harada Y; Matsushima Y; Miyashita N; Fukumori Y; Inai S; Moriwaki K; Yonekawa H
    Immunogenetics; 1991; 33(1):18-23. PubMed ID: 1995474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).
    Klob WP; Müller-Eberhard HJ
    J Exp Med; 1976 May; 143(5):1131-9. PubMed ID: 1262784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional domains of the alpha subunit of the eighth component of human complement: identification and characterization of a distinct binding site for the gamma chain.
    Brickner A; Sodetz JM
    Biochemistry; 1985 Aug; 24(17):4603-7. PubMed ID: 4063342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deficiency of the alpha-gamma-subunit of the eighth complement component in the rabbit.
    Komatsu M; Yamamoto K; Kawashima T; Migita S
    J Immunol; 1985 Apr; 134(4):2607-9. PubMed ID: 3973389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum.
    Høgåsen K; Mollnes TE; Nürnberger W; Pausa M; Fukumori Y; Tedesco F
    Scand J Immunol; 1998 Sep; 48(3):261-8. PubMed ID: 9743210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.
    Tedesco F; Rottini G; Patriarca P
    J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).
    Alper CA; Marcus D; Raum D; Petersen BH; Spira TJ
    J Clin Invest; 1983 Nov; 72(5):1526-31. PubMed ID: 6415112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the formation of the complement membrane-attack complex by a monoclonal antibody to the complement component C8 alpha subunit.
    Abraha A; Luzio JP
    Biochem J; 1989 Dec; 264(3):933-6. PubMed ID: 2695070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal bactericidal capacity against Neisseria meningitidis in serum from a patient with a hemolytically inactive complement factor 8 (C8).
    Strate M; Olsen H; Teisner B; Brandslund I
    Acta Pathol Microbiol Immunol Scand B; 1983 Dec; 91(6):431-4. PubMed ID: 6424405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the human C8 subunits in complement-mediated bacterial killing: evidence that C8 gamma is not essential.
    Parker CL; Sodetz JM
    Mol Immunol; 2002 Nov; 39(7-8):453-8. PubMed ID: 12413696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.